{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:03:42Z","timestamp":1763665422172,"version":"build-2065373602"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00105-024-05297-9","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T10:02:32Z","timestamp":1708077752000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lokalisierte Sklerodermie","Localized scleroderma"],"prefix":"10.1007","volume":"75","author":[{"given":"Suzan","family":"Al-Gburi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Moinzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"5297_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","volume":"15","author":"JHW Distler","year":"2019","unstructured":"Distler\u00a0JHW, Gy\u00f6rfi\u00a0A\u2011H, Ramanujam\u00a0M et\u00a0al (2019) Shared and distinct mechanisms of fibrosis. Nat Rev Rheumatol 15:705\u2013730. https:\/\/doi.org\/10.1038\/s41584-019-0322-7","journal-title":"Nat Rev Rheumatol"},{"key":"5297_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1600-0625.2010.01082.x","volume":"19","author":"N Hunzelmann","year":"2010","unstructured":"Hunzelmann\u00a0N, Krieg\u00a0T (2010) Scleroderma: From pathophysiology to novel therapeutic approaches. Exp Dermatol 19:393\u2013400. https:\/\/doi.org\/10.1111\/j.1600-0625.2010.01082.x","journal-title":"Exp Dermatol"},{"key":"5297_CR3","series-title":"AWMF-Register-Nr 013-066, 2023","first-page":"13","volume-title":"S2k-Leitlinie Diagnostik und Therapie zirkumskripten Sklerodermie","author":"A Kreuter","year":"2023","unstructured":"Kreuter\u00a0A, Moinzadeh\u00a0P, Kinberger\u00a0M et\u00a0al (2023) S2k-Leitlinie Diagnostik und Therapie zirkumskripten Sklerodermie. AWMF-Register-Nr 013-066, 2023, S\u00a013\u201366"},{"key":"5297_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.12968\/hmed.2019.80.9.530","volume":"80","author":"M Hughes","year":"2019","unstructured":"Hughes\u00a0M, Herrick\u00a0AL (2019) Systemic sclerosis. Br J Hosp Med 80:530\u2013536. https:\/\/doi.org\/10.12968\/hmed.2019.80.9.530","journal-title":"Br J Hosp Med"},{"key":"5297_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/978-3-662-49544-5_53","volume-title":"Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie","author":"N Hunzelmann","year":"2018","unstructured":"Hunzelmann\u00a0N, Krieg\u00a0T (2018) Sklerodermie. In: Plewig\u00a0G, Ruzicka\u00a0T, Kaufmann\u00a0R et\u00a0al (Hrsg) Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie. Springer, Berlin Heidelberg, S\u00a0919\u2013936"},{"key":"5297_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/jdv.14458","volume":"31","author":"R Knobler","year":"2017","unstructured":"Knobler\u00a0R, Moinzadeh\u00a0P, Hunzelmann\u00a0N et\u00a0al (2017) European dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J\u00a0Eur Acad Dermatol Venereol 31:1401\u20131424. https:\/\/doi.org\/10.1111\/jdv.14458","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5297_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.clindermatol.2018.04.005","volume":"36","author":"S Florez-Pollack","year":"2018","unstructured":"Florez-Pollack\u00a0S, Kunzler\u00a0E, Jacobe\u00a0HT (2018) Morphea: current concepts. Clin Dermatol 36:475\u2013486. https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.005","journal-title":"Clin Dermatol"},{"key":"5297_CR8","first-page":"73","volume":"24","author":"LS Peterson","year":"1997","unstructured":"Peterson\u00a0LS, Nelson\u00a0AM, Su\u00a0WP et\u00a0al (1997) The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993. J\u00a0Rheumatol 24:73\u201380","journal-title":"J Rheumatol"},{"key":"5297_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/rheumatology\/27.4.286","volume":"27","author":"A Silman","year":"1988","unstructured":"Silman\u00a0A, Jannini\u00a0S, Symmons\u00a0D et\u00a0al (1988) An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 27:286\u2013290. https:\/\/doi.org\/10.1093\/rheumatology\/27.4.286","journal-title":"Br J Rheumatol"},{"key":"5297_CR10","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.4065\/70.11.1068","volume":"70","author":"LS Peterson","year":"1995","unstructured":"Peterson\u00a0LS, Nelson\u00a0AM, Su\u00a0WP (1995) Classification of morphea (localized scleroderma). Mayo Clin Proc 70:1068\u20131076. https:\/\/doi.org\/10.4065\/70.11.1068","journal-title":"Mayo Clin Proc"},{"key":"5297_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s1085-5629(98)80059-x","volume":"17","author":"DL Tuffanelli","year":"1998","unstructured":"Tuffanelli\u00a0DL (1998) Localized scleroderma. Semin Cutan Med Surg 17:27\u201333. https:\/\/doi.org\/10.1016\/s1085-5629(98)80059-x","journal-title":"Semin Cutan Med Surg"},{"key":"5297_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000246685","volume":"190","author":"D Kencka","year":"2009","unstructured":"Kencka\u00a0D, Blaszczyk\u00a0M, Jab\u0142o\u0144ska\u00a0S (2009) Atrophoderma Pasini-Pierini Is a\u00a0Primary Atrophic Abortive Morphea. Dermatology 190:203\u2013206. https:\/\/doi.org\/10.1159\/000246685","journal-title":"Dermatology"},{"key":"5297_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2214\/AJR.07.2163","volume":"190","author":"M Horger","year":"2008","unstructured":"Horger\u00a0M, Fierlbeck\u00a0G, Kuemmerle-Deschner\u00a0J et\u00a0al (2008) MRI findings in deep and generalized morphea (localized scleroderma). AJR Am J Roentgenol 190:32\u201339. https:\/\/doi.org\/10.2214\/AJR.07.2163","journal-title":"AJR Am J Roentgenol"},{"key":"5297_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1365-4362.1991.tb04356.x","volume":"30","author":"K Sayama","year":"1991","unstructured":"Sayama\u00a0K, Chen\u00a0M, Shiraishi\u00a0S et\u00a0al (1991) Morphea profunda. Int J Dermatol 30:873\u2013875. https:\/\/doi.org\/10.1111\/j.1365-4362.1991.tb04356.x","journal-title":"Int J Dermatol"},{"key":"5297_CR15","first-page":"308","volume":"65","author":"M Gordon","year":"1998","unstructured":"Gordon\u00a0M, Lebwohl\u00a0M (1998) Generalized morphea. Mt Sinai J Med 65:308","journal-title":"Mt Sinai J Med"},{"key":"5297_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/archderm.1980.01640260045011","volume":"116","author":"JL Diaz-Perez","year":"1980","unstructured":"Diaz-Perez\u00a0JL, Connolly\u00a0SM, Winkelmann\u00a0RK (1980) Disabling pansclerotic morphea of children. Arch Dermatol 116:169\u2013173","journal-title":"Arch Dermatol"},{"key":"5297_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3899\/jrheum.130029","volume":"41","author":"A Kim","year":"2014","unstructured":"Kim\u00a0A, Marinkovich\u00a0N, Vasquez\u00a0R et\u00a0al (2014) Clinical features of patients with morphea and the pansclerotic subtype: a\u00a0cross-sectional study from the morphea in adults and children cohort. J\u00a0Rheumatol 41:106\u2013112. https:\/\/doi.org\/10.3899\/jrheum.130029","journal-title":"J Rheumatol"},{"key":"5297_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1525-1470.2002.00033.x","volume":"19","author":"U Wollina","year":"2002","unstructured":"Wollina\u00a0U, Buslau\u00a0M, Weyers\u00a0W (2002) Squamous cell carcinoma in pansclerotic morphea of childhood. Pediatr Dermatol 19:151\u2013154. https:\/\/doi.org\/10.1046\/j.1525-1470.2002.00033.x","journal-title":"Pediatr Dermatol"},{"key":"5297_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-205737","author":"I Grewal","year":"2014","unstructured":"Grewal\u00a0I, Khan\u00a0O, Davis\u00a0W (2014) Squamous cell carcinoma and eosinophilia in a\u00a0long-term course of pansclerotic morphea. Case Reports. https:\/\/doi.org\/10.1136\/bcr-2014-205737","journal-title":"Case Reports"},{"key":"5297_CR20","first-page":"339","volume":"92","author":"HJ Cohen","year":"1965","unstructured":"Cohen\u00a0HJ, Frank\u00a0SB (1965) Linear scleroderma. Arch Dermatol 92:339\u2013342","journal-title":"Arch Dermatol"},{"key":"5297_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/1573397112666160907105434","volume":"13","author":"M Tratenberg","year":"2017","unstructured":"Tratenberg\u00a0M, Gutwein\u00a0F, Rao\u00a0V et\u00a0al (2017) Localized scleroderma: a\u00a0clinical review. Curr Rheumatol Rev 13:86\u201392. https:\/\/doi.org\/10.2174\/1573397112666160907105434","journal-title":"Curr Rheumatol Rev"},{"key":"5297_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-12-27","volume":"12","author":"C Saad Magalh\u00e3es","year":"2014","unstructured":"Saad Magalh\u00e3es\u00a0C, Fernandes\u00a0TDAP, Fernandes\u00a0TD et\u00a0al (2014) A\u00a0cross-sectional electromyography assessment in linear scleroderma patients. Pediatr Rheumatol Online\u00a0J 12:1\u20135. https:\/\/doi.org\/10.1186\/1546-0096-12-27","journal-title":"Pediatr Rheumatol Online J"},{"key":"5297_CR23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s00105-018-4266-7","volume":"69","author":"P Moinzadeh","year":"2018","unstructured":"Moinzadeh\u00a0P, Kreuter\u00a0A, Krieg\u00a0T et\u00a0al (2018) Morphea or localized scleroderma and extragenital lichen sclerosus. Hautarzt 69:892\u2013900. https:\/\/doi.org\/10.1007\/s00105-018-4266-7","journal-title":"Hautarzt"},{"key":"5297_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194517","author":"E Ulc","year":"2021","unstructured":"Ulc\u00a0E, Rudnicka\u00a0L, Wa\u015bkiel-burnat\u00a0A et\u00a0al (2021) Therapeutic and reconstructive management options in scleroderma (morphea) en coup de sabre in children and adults. A\u00a0systematic literature review. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm10194517","journal-title":"J Clin Med"},{"key":"5297_CR25","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1007\/s10067-020-05289-9","volume":"39","author":"P Kashyape","year":"2020","unstructured":"Kashyape\u00a0P, D\u2019Souza\u00a0AP, Fathalla\u00a0B (2020) En coup de sabre presenting as status epilepticus. Clin Rheumatol 39:3885\u20133886. https:\/\/doi.org\/10.1007\/s10067-020-05289-9","journal-title":"Clin Rheumatol"},{"key":"5297_CR26","doi-asserted-by":"publisher","unstructured":"Sommer\u00a0A, Gambichler T, Bacharach-Buhles M et\u00a0al (2006) Clinical and serological characteristics of progressive facial hemiatrophy: A case series of 12 patients. J Am Acad Dermatol 54(2):227\u2013233. https:\/\/doi.org\/10.1016\/j.jaad.2005.10.020","DOI":"10.1016\/j.jaad.2005.10.020"},{"key":"5297_CR27","doi-asserted-by":"publisher","unstructured":"Tollefson\u00a0MM, Witman\u00a0PM (2007) En coup de sabre morphea and Parry-Romberg syndrome: A retrospective review of 54 patients. J Am Acad Dermatol 56(2):257\u2013263. https:\/\/doi.org\/10.1016\/j.jaad.2006.10.959","DOI":"10.1016\/j.jaad.2006.10.959"},{"key":"5297_CR28","unstructured":"Jablonska\u00a0S (1975) Facial hemiatrophy and it\u2019s relation to localized scleroderma. Scleroderma and pseudoscleroderma PZWL, Warsaw 1975:537\u2013548."},{"key":"5297_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11926-017-0700-6","volume":"19","author":"DR Mazori","year":"2017","unstructured":"Mazori\u00a0DR, Femia\u00a0AN, Vleugels\u00a0RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19:74. https:\/\/doi.org\/10.1007\/s11926-017-0700-6","journal-title":"Curr Rheumatol Rep"},{"key":"5297_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/bjd.18097","volume":"182","author":"NM Teske","year":"2020","unstructured":"Teske\u00a0NM, Jacobe\u00a0HT (2020) Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphoea by severity and identify clinically significant change. Br J Dermatol 182:398\u2013404. https:\/\/doi.org\/10.1111\/bjd.18097","journal-title":"Br J Dermatol"},{"key":"5297_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","volume":"49","author":"T Arkachaisri","year":"2010","unstructured":"Arkachaisri\u00a0T, Vilaiyuk\u00a0S, Torok\u00a0KS et\u00a0al (2010) Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease damage: a\u00a0proof-of-concept study. Baillieres Clin Rheumatol 49:373\u2013381. https:\/\/doi.org\/10.1093\/rheumatology\/kep361","journal-title":"Baillieres Clin Rheumatol"},{"key":"5297_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","volume":"64","author":"N Fett","year":"2011","unstructured":"Fett\u00a0N, Werth\u00a0VP (2011) Update on morphea: part II. Outcome measures and treatment. J\u00a0Am Acad Dermatol 64:231\u2013234. https:\/\/doi.org\/10.1016\/j.jaad.2010.05.046","journal-title":"J Am Acad Dermatol"},{"key":"5297_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jamadermatol.2022.6365","volume":"159","author":"MT Garc\u00eda-Romero","year":"2023","unstructured":"Garc\u00eda-Romero\u00a0MT, Tollefson\u00a0M, Pope\u00a0E et\u00a0al (2023) Development and validation of the morphea activity measure in patients with pediatric morphea. JAMA Dermatol 159:299\u2013307. https:\/\/doi.org\/10.1001\/jamadermatol.2022.6365","journal-title":"JAMA Dermatol"},{"key":"5297_CR34","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3899\/jrheum.081284","volume":"36","author":"T Arkachaisri","year":"2009","unstructured":"Arkachaisri\u00a0T, Vilaiyuk\u00a0S, Li\u00a0S et\u00a0al (2009) The localized scleroderma skin severity index and physician global assessment of disease activity: a\u00a0work in progress toward development of localized scleroderma outcome measures. J\u00a0Rheumatol 36:2819\u20132829. https:\/\/doi.org\/10.3899\/jrheum.081284","journal-title":"J Rheumatol"},{"key":"5297_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","volume":"69","author":"CE Kelsey","year":"2013","unstructured":"Kelsey\u00a0CE, Torok\u00a0KS (2013) The Localized Scleroderma Cutaneous Assessment tool: responsiveness to change in a\u00a0pediatric clinical population. J\u00a0Am Acad Dermatol 69:214\u2013220. https:\/\/doi.org\/10.1016\/j.jaad.2013.02.007","journal-title":"J Am Acad Dermatol"},{"key":"5297_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-5945-1-9","volume":"1","author":"T Gambichler","year":"2001","unstructured":"Gambichler\u00a0T, Kreuter\u00a0A, Hoffmann\u00a0K et\u00a0al (2001) Bilateral linear scleroderma \u201cen coup de sabre\u201d associated with facial atrophy and neurological complications. BMC Dermatol 1:9. https:\/\/doi.org\/10.1186\/1471-5945-1-9","journal-title":"BMC Dermatol"},{"key":"5297_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/719685","author":"TN Amaral","year":"2012","unstructured":"Amaral\u00a0TN, Marques Neto\u00a0JF, Lapa\u00a0AT et\u00a0al (2012) Neurologic involvement in scleroderma en coup de sabre. Autoimmune Dis. https:\/\/doi.org\/10.1155\/2012\/719685","journal-title":"Autoimmune Dis"},{"key":"5297_CR38","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.joms.2013.09.044","volume":"72","author":"P Scolozzi","year":"2014","unstructured":"Scolozzi\u00a0P, Herzog\u00a0G (2014) Total mandibular subapical osteotomy and Le Fort I osteotomy using piezosurgery and computer-aided designed and manufactured surgical splints: a\u00a0favorable combination of three techniques in the management of severe mouth asymmetry in Parry-Romberg syndro. J\u00a0Oral Maxillofac Surg Med Pathol 72:991\u2013999. https:\/\/doi.org\/10.1016\/j.joms.2013.09.044","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"5297_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1177\/0883073820931253","volume":"35","author":"RR Seese","year":"2020","unstructured":"Seese\u00a0RR, Glaser\u00a0D, Furtado\u00a0A et\u00a0al (2020) Unilateral neuroimaging findings in pediatric craniofacial scleroderma: parry-romberg syndrome and En Coup de Sabre. J\u00a0Child Neurol 35:753\u2013762. https:\/\/doi.org\/10.1177\/0883073820931253","journal-title":"J Child Neurol"},{"key":"5297_CR40","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00105-020-04621-3","volume":"71","author":"H Stroh","year":"2020","unstructured":"Stroh\u00a0H, Jaschinski\u00a0C, Enk\u00a0A et\u00a0al (2020) Lineare Sklerodermie \u201een coup de sabre\u201c mit neurologischer und okul\u00e4rer Beteiligung. Hautarzt 71:802\u2013804. https:\/\/doi.org\/10.1007\/s00105-020-04621-3","journal-title":"Hautarzt"},{"key":"5297_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-021-00512-6","volume":"19","author":"H Knights","year":"2021","unstructured":"Knights\u00a0H, Minas\u00a0E, Khan\u00a0F et\u00a0al (2021) Magnetic resonance imaging findings in children with parry-romberg syndrome and en coup de sabre. Pediatr Rheumatol 19:1\u201310. https:\/\/doi.org\/10.1186\/s12969-021-00512-6","journal-title":"Pediatr Rheumatol"},{"key":"5297_CR42","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/pde.12001","volume":"29","author":"YE Chiu","year":"2012","unstructured":"Chiu\u00a0YE, Vora\u00a0S, Kwon\u00a0E\u2011KM et\u00a0al (2012) A\u00a0significant proportion of children with morphea En Coup De Sabre and parry-romberg syndrome have neuroimaging findings. Pediatr Dermatol 29:738\u2013748. https:\/\/doi.org\/10.1111\/pde.12001","journal-title":"Pediatr Dermatol"},{"key":"5297_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.survophthal.2016.03.009","volume":"61","author":"F Bucher","year":"2016","unstructured":"Bucher\u00a0F, Fricke\u00a0J, Neugebauer\u00a0A et\u00a0al (2016) Ophthalmological manifestations of parry-romberg syndrome. Surv Ophthalmol 61:693\u2013701. https:\/\/doi.org\/10.1016\/j.survophthal.2016.03.009","journal-title":"Surv Ophthalmol"},{"key":"5297_CR44","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","volume":"91","author":"ME Zannin","year":"2007","unstructured":"Zannin\u00a0ME, Martini\u00a0G, Athreya\u00a0BH et\u00a0al (2007) Ocular involvement in children with localised scleroderma: a\u00a0multi-centre study. Br J Ophthalmol 91:1311\u20131314. https:\/\/doi.org\/10.1136\/bjo.2007.116038","journal-title":"Br J Ophthalmol"},{"key":"5297_CR45","doi-asserted-by":"crossref","unstructured":"Defabianis P (2003) Movement of the temporomandibular joint with effects on facial development. 28:33\u201338","DOI":"10.17796\/jcpd.28.1.607q556111778521"},{"key":"5297_CR46","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.clindermatol.2013.01.011","volume":"31","author":"T Gambichler","year":"2013","unstructured":"Gambichler\u00a0T, Terras\u00a0S, Kreuter\u00a0A (2013) Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies. Clin Dermatol 31:438\u2013454. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.01.011","journal-title":"Clin Dermatol"},{"key":"5297_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-5945-4-11","volume":"4","author":"F Breuckmann","year":"2004","unstructured":"Breuckmann\u00a0F, Gambichler\u00a0T, Altmeyer\u00a0P et\u00a0al (2004) UVA\/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a\u00a0research based review. BMC Dermatol 4:11. https:\/\/doi.org\/10.1186\/1471-5945-4-11","journal-title":"BMC Dermatol"},{"key":"5297_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1468-3083.2007.02576.x","volume":"22","author":"EBM Kroft","year":"2008","unstructured":"Kroft\u00a0EBM, Van De Kerkhof\u00a0PCM, Gerritsen\u00a0MJP et\u00a0al (2008) Period of remission after treatment with UVA\u20111 in sclerodermic skin diseases. J\u00a0Eur Acad Dermatol Venereol 22:839\u2013844. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02576.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5297_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s13555-016-0136-3","volume":"6","author":"J Hassani","year":"2016","unstructured":"Hassani\u00a0J, Feldman\u00a0SR (2016) Phototherapy in Scleroderma. Dermatol Ther 6:519\u2013553. https:\/\/doi.org\/10.1007\/s13555-016-0136-3","journal-title":"Dermatol Ther"},{"key":"5297_CR50","first-page":"4280","volume":"9","author":"U Keyal","year":"2017","unstructured":"Keyal\u00a0U, Bhatta\u00a0AK, Wang\u00a0XL (2017) UVA1 a\u00a0promising approach for scleroderma. Am J Transl Res 9:4280\u20134287","journal-title":"Am J Transl Res"},{"key":"5297_CR51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5114\/ceji.2012.32731","volume":"4","author":"A Osmola-Ma\u0144kowska","year":"2012","unstructured":"Osmola-Ma\u0144kowska\u00a0A, Danczak-Pazdrowska\u00a0A, Olek-Hrab\u00a0K et\u00a0al (2012) Role of UVA1 phototherapy in treatment of scleroderma and scleroderma-like disorders\u201d. Cent Eur J Immunol 4:391\u2013398. https:\/\/doi.org\/10.5114\/ceji.2012.32731","journal-title":"Cent Eur J Immunol"},{"key":"5297_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2018.00237","volume":"5","author":"T Gambichler","year":"2018","unstructured":"Gambichler\u00a0T, Schmitz\u00a0L (2018) Ultraviolet A1 phototherapy for fibrosing conditions. Front Med 5:1\u20138. https:\/\/doi.org\/10.3389\/fmed.2018.00237","journal-title":"Front Med"},{"key":"5297_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2133.1997.tb03804.x","volume":"137","author":"M Wlaschek","year":"1997","unstructured":"Wlaschek\u00a0M, Peus\u00a0D, Achterberg\u00a0V et\u00a0al (1997) Protease inhibitors protect growth factor activity in chronic wounds. Br J Dermatol 137:646","journal-title":"Br J Dermatol"},{"key":"5297_CR54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0891-5849(96)00404-2","volume":"22","author":"P Brenneisen","year":"1997","unstructured":"Brenneisen\u00a0P, Briviba\u00a0K, Wlaschek\u00a0M et\u00a0al (1997) Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase\/MMP\u20111 in human dermal fibroblasts. Free Radic Biol Med 22:515\u2013524. https:\/\/doi.org\/10.1016\/S0891-5849(96)00404-2","journal-title":"Free Radic Biol Med"},{"key":"5297_CR55","first-page":"1247","volume":"378","author":"K Scharffetter-Kochanek","year":"1997","unstructured":"Scharffetter-Kochanek\u00a0K, Wlaschek\u00a0M, Brenneisen\u00a0P et\u00a0al (1997) UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol Chem 378:1247\u20131257","journal-title":"Biol Chem"},{"key":"5297_CR56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/2397198320983240","volume":"6","author":"J Talia","year":"2021","unstructured":"Talia\u00a0J, Bitar\u00a0C, Wang\u00a0Y et\u00a0al (2021) A\u00a0case of recalcitrant linear morphea responding to subcutaneous abatacept. J\u00a0scleroderma Relat Disord 6:194\u2013198. https:\/\/doi.org\/10.1177\/2397198320983240","journal-title":"J scleroderma Relat Disord"},{"key":"5297_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jdcr.2022.09.024","volume":"30","author":"S Lonowski","year":"2022","unstructured":"Lonowski\u00a0S, Goldman\u00a0N, Kassamali\u00a0B et\u00a0al (2022) Tocilizumab for refractory morphea in adults: a\u00a0case series. JAAD Case Rep 30:27\u201329. https:\/\/doi.org\/10.1016\/j.jdcr.2022.09.024","journal-title":"JAAD Case Rep"},{"key":"5297_CR58","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","volume":"387","author":"D Khanna","year":"2016","unstructured":"Khanna\u00a0D, Denton\u00a0CP, Jahreis\u00a0A et\u00a0al (2016) Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a\u00a0phase\u00a02, randomised, controlled trial. Lancet 387:2630\u20132640. https:\/\/doi.org\/10.1016\/S0140-6736(16)00232-4","journal-title":"Lancet"},{"key":"5297_CR59","doi-asserted-by":"publisher","first-page":"e15437","DOI":"10.1111\/dth.15437","volume":"35","author":"S McGaugh","year":"2022","unstructured":"McGaugh\u00a0S, Kallis\u00a0P, De Benedetto\u00a0A et\u00a0al (2022) Janus kinase inhibitors for treatment of morphea and systemic sclerosis: a\u00a0literature review. Dermatol Ther 35:e15437. https:\/\/doi.org\/10.1111\/dth.15437","journal-title":"Dermatol Ther"},{"key":"5297_CR60","doi-asserted-by":"crossref","unstructured":"Strong AL, Rubin JP, Kozlow JH et\u00a0al (2019) Fat grafting for the treatment of scleroderma. Plast Reconstr Surg 144:","DOI":"10.1097\/PRS.0000000000006291"},{"key":"5297_CR61","doi-asserted-by":"publisher","first-page":"e3373","DOI":"10.1097\/GOX.0000000000003373","volume":"9","author":"AL Strong","year":"2021","unstructured":"Strong\u00a0AL, Adidharma\u00a0W, Brown\u00a0OH et\u00a0al (2021) Fat grafting subjectively improves facial skin elasticity and hand function of scleroderma patients. Plast Reconstr Surgery Glob Open 9:e3373. https:\/\/doi.org\/10.1097\/GOX.0000000000003373","journal-title":"Plast Reconstr Surgery Glob Open"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-024-05297-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T15:04:20Z","timestamp":1708700660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-024-05297-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["5297"],"URL":"https:\/\/doi.org\/10.1007\/s00105-024-05297-9","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"10 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Al-Gburi, A.\u00a0Kreuter und P.\u00a0Moinzadeh geben an, dass f\u00fcr diesen Beitrag kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}